Phibro Animal Health (NASDAQ:PAHC) Trading Down 6.5%

Phibro Animal Health Co. (NASDAQ:PAHC) fell 6.5% on Wednesday . The company traded as low as $12.73 and last traded at $12.73. 55,607 shares were traded during trading, a decline of 61% from the average session volume of 140,861 shares. The stock had previously closed at $13.61.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Tuesday, April 9th.

Phibro Animal Health Stock Performance

The stock has a 50 day simple moving average of $12.83 and a 200 day simple moving average of $11.77. The company has a current ratio of 3.12, a quick ratio of 1.60 and a debt-to-equity ratio of 1.66. The stock has a market cap of $515.57 million, a P/E ratio of 35.36, a price-to-earnings-growth ratio of 4.63 and a beta of 0.75.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.06. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. The firm had revenue of $249.90 million for the quarter, compared to analyst estimates of $242.91 million. On average, equities analysts expect that Phibro Animal Health Co. will post 1.12 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Wednesday, March 6th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 3.77%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 133.33%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds have recently added to or reduced their stakes in the stock. Brandes Investment Partners LP increased its stake in shares of Phibro Animal Health by 38.5% in the 3rd quarter. Brandes Investment Partners LP now owns 1,873,300 shares of the company’s stock valued at $23,922,000 after purchasing an additional 520,697 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of Phibro Animal Health by 165.9% in the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after purchasing an additional 102,793 shares during the last quarter. GSA Capital Partners LLP increased its stake in shares of Phibro Animal Health by 227.0% in the 3rd quarter. GSA Capital Partners LLP now owns 81,647 shares of the company’s stock valued at $1,043,000 after purchasing an additional 56,676 shares during the last quarter. BNP Paribas Financial Markets increased its stake in shares of Phibro Animal Health by 290.2% in the 4th quarter. BNP Paribas Financial Markets now owns 73,287 shares of the company’s stock valued at $849,000 after purchasing an additional 54,506 shares during the last quarter. Finally, Brandywine Global Investment Management LLC increased its stake in shares of Phibro Animal Health by 21.1% in the 3rd quarter. Brandywine Global Investment Management LLC now owns 257,200 shares of the company’s stock valued at $3,284,000 after purchasing an additional 44,900 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.